Pillar tarsoconjunctival flap: An alternative approach for the management of refractory corneal ulcer

Author:

Zamorano-Martin Francisco1ORCID,Rocha-de-Lossada Carlos234ORCID,Rodriguez-Calvo-de-Mora Marina1ORCID,Sanchez-España Juan Carlos5,Garcia-Lorente Maria1ORCID,Borroni Davide678,Peraza-Nieves Jorge5,Ortiz-Perez Santiago2ORCID,Torras-Sanvicens Josep5

Affiliation:

1. Department of Ophthalmology, Regional University Hospital of Malaga, Malaga, Spain

2. Department of Ophthalmology, Virgen de las Nieves University Hospital, Granada, Spain

3. Department of Ophthalmology (Qvision), Vithas Almeria, Almeria, Spain

4. Ceuta Medical Center, Ceuta, Spain

5. Department of Ophthalmology, Hospital Clinic de Barcelona Institut Clinic D’Oftalmologia, Barcelona, Spain

6. International Center for Ocular Physiopatology, The Veneto Eye Bank Foundation, Venice, Italy

7. Department of Doctoral Studies, Riga Stradins University, Riga, Latvia

8. Advalia – Cornea Research Unit, Milan, Italy

Abstract

Purpose To report the effectiveness of the surgical procedure of the tarsoconjunctival flap (FTC) in patients with severe ocular surface impairment refractory to previous conventional treatments. Methods A retrospective, noncomparative, consecutive case series. Results Pillar tarsoconjunctival flap (PTCF) was performed in eight eyes of eight patients. Three patients had neurotrophic corneal ulcer (NCU), three had exposure keratopathy and two had corneal melting. Seven of them had satisfactory postoperative results, showing total corneal re-epithelialization that lasted throughout the postoperative follow-up (mean 10.33 ± 2.65 months [SD], range 6 to 12 months). Mean time for the re-epithelization was 11.28 ± 8.97 days [SD] (range 4 to 30 days). Conclusion This study suggest PTCF is a valid alternative to tarsorrhaphy in cases of persistent epithelial defect (PED) or NCU resistant to conventional treatments. Notwithstanding, prospective comparative trials comparing PTFC with conventional and/or novel therapies in PED or NCU are needed to corroborate these findings.

Publisher

SAGE Publications

Subject

Ophthalmology,General Medicine

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3